<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03906786</url>
  </required_header>
  <id_info>
    <org_study_id>CEIm-CHUIMI-2017/974</org_study_id>
    <nct_id>NCT03906786</nct_id>
  </id_info>
  <brief_title>Motivational Interviewing and Self-care in Type 1 Diabetes: Randomized Controlled Clinical Trial.</brief_title>
  <official_title>Motivational Interviewing and Self-care in Type 1 Diabetes: Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Insular Gran Canaria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Menarini Group</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Insular Gran Canaria</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 1 diabetes requires a high level of involvement of patients to obtain good control by
      following complex therapeutic recommendations. Motivational Interviewing has proven to be
      effective in changing behaviors in sedentary people, with addictions and with obesity.

      Our objective is to evaluate the impact of an intervention with Motivational Interviewing in
      patients with type 1 diabetes, through a randomized controlled clinical trial. At least sixty
      patients with type 1 diabetes will be included with HbA1c&gt; 8% that will be randomized with a
      ratio of 1: 1. In the intervention group, Motivational Interviewing will be applied in the
      routine clinical appointments with the Endocrinologist, while the control group will receive
      the same visits but in a traditional way.

      The primary result will be self-care behaviors according to a validated questionnaire.
      Secondary outcomes include: HbA1c, number of hypoglycemia, motivation with self-care,
      self-efficacy, quality of life, compliance with patients' own objectives, lipid profile,
      weight and blood pressure.

      The professionals will be trained in Motivational Interviewing with the objective of favoring
      the adherence to self-care, the motivation of the patient and improving doctor-patient
      relationship. They will also be evaluated through a specific questionnaire.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 7, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to self-care behaviors. The Diabetes Self-Care Inventory-Revised</measure>
    <time_frame>12 months</time_frame>
    <description>The validated Spanish version of The Diabetes Self-Care Inventory-Revised version (SCI-R) (18) was used. This inventory consists of 15 items that refer to self-care behaviors in the treatment of diabetes, which are scored on a Likert scale ranging from (1 = &quot;never&quot; to 5 = &quot;always&quot;). The scores are converted with a formula and the responses range from 0-100; higher scores indicate higher levels of self-care</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Type1diabetes</condition>
  <arm_group>
    <arm_group_label>motivacional interviewing group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>motivational interviewing</intervention_name>
    <description>The intervention will consist of 4 structured medical consultations in the form of a motivational interviewing compared to usual care, covering a 12-month intervention period. In both groups, the frequency of visits (c / 3 months) and the variables collected will be the same.</description>
    <arm_group_label>motivacional interviewing group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with DM1 seen in outpatient clinics of Endocrinology and Nutrition with at
             least one year of evolution, HbA1c&gt; 8% and / or severe hypoglycemia in the previous 6
             months

        Exclusion Criteria:

          -  Gestion underway or scheduled for the next 9 months. Any circumstance that, in the
             opinion of the investigators, could interfere with the follow-up of the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana M Wägner</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Insular de Gran Canaria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana M Wägner</last_name>
    <phone>+34 928453431</phone>
    <email>ana.wagner@ulpgc.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dácil Alvarado</last_name>
    <phone>+34 928453431</phone>
    <email>dacil.alvarado@ulpgc.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario Materno-infantil de Las Palmas</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <state>Las Palmas</state>
        <zip>35016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana M Wägner, M.D.</last_name>
      <phone>+34 928453431</phone>
      <email>ana.wagner@upgc.es</email>
    </contact>
    <contact_backup>
      <last_name>Dácil Alvarado</last_name>
      <phone>+34 928453431</phone>
      <email>dacil.alvarado@ulpgc.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 25, 2019</study_first_submitted>
  <study_first_submitted_qc>April 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>April 5, 2019</last_update_submitted>
  <last_update_submitted_qc>April 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Insular Gran Canaria</investigator_affiliation>
    <investigator_full_name>Rosa María Sánchez Hernández</investigator_full_name>
    <investigator_title>Clinical Doctor</investigator_title>
  </responsible_party>
  <keyword>self-care</keyword>
  <keyword>motivational interviewing</keyword>
  <keyword>doctor-pacient relationship</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonimized results will be available upon request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Protocol and statistical plan: as son as posible Access to results. Upon publication</ipd_time_frame>
    <ipd_access_criteria>Study protocol and statistical analysis plan will be published (draft in progress) Individual data/results (anonimized) will be available upon request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

